Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy

被引：46
|
作者：
Visentin, Andrea [1 ,2 ]
Compagno, Nicolo [1 ,2 ]
Cinetto, Francesco [1 ,2 ]
Imbergamo, Silvia [1 ]
Zambello, Renato [1 ,2 ]
Piazza, Francesco [1 ,2 ]
Semenzato, Gianpietro [1 ,2 ]
Trentin, Livio [1 ,2 ]
Agostini, Carlo [1 ,2 ]
机构：
[1] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, I-35100 Padua, Italy
[2] Ctr Eccellenza Ric Biomed Avanzata, Venetian Inst Mol Med, Milan, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷 / 12期
关键词：
CLL; infections; secondary hypogammaglobulinemia; hypogammaglobulinemia; immunoglobulin replacement therapy; HYPOGAMMAGLOBULINEMIA; COMPLICATIONS; GUIDELINES; DIAGNOSIS; SECONDARY; DISEASE;
D O I：
10.3324/haematol.2015.126763
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E515 / E518
页数：4
相关论文
共 50 条
  • [21] Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis
    Murru, Roberta
    Galitzia, Andrea
    Barabino, Luca
    Presicci, Roberta
    La Nasa, Giorgio
    Caocci, Giovanni
    ANNALS OF HEMATOLOGY, 2024, 103 (05) : 1655 - 1664
  • [22] Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors
    Pleyer, Christopher
    Sun, Clare
    Desai, Sanjal
    Ahn, Inhye E.
    Tian, Xin
    Nierman, Pia
    Soto, Susan
    Superata, Jeanine
    Valdez, Janet
    Lotter, Jennifer
    Wiestner, Adrian
    LEUKEMIA & LYMPHOMA, 2020, 61 (10) : 2375 - 2382
  • [23] Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections
    Hartmut Link
    Markus Kerkmann
    Laura Holtmann
    Supportive Care in Cancer, 2022, 30 : 5187 - 5200
  • [24] Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients
    Visentin, Andrea
    Imbergamo, Silvia
    Gurrieri, Carmela
    Frezzato, Federica
    Trimarco, Valentina
    Martini, Veronica
    Severin, Filippo
    Raggi, Flavia
    Scomazzon, Edoardo
    Facco, Monica
    Piazza, Francesco
    Semenzato, Gianpietro
    Trentin, Livio
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : 103 - 111
  • [25] Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy
    Vodarek, Pavel
    Ecsiova, Dominika
    Rezacova, Vladimira
    Soucek, Ondrej
    Simkovic, Martin
    Vokurkova, Doris
    Belada, David
    Zak, Pavel
    Smolej, Lukas
    CANCER MEDICINE, 2024, 13 (15):
  • [26] Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
    Elter, Thomas
    Vehreschild, Janne J.
    Gribben, John
    Cornely, Oliver A.
    Engert, Andreas
    Hallek, Michael
    ANNALS OF HEMATOLOGY, 2009, 88 (02) : 121 - 132
  • [27] Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
    Serhat Çelik
    Leylagül Kaynar
    Zeynep Tuğba Güven
    Mustafa Baydar
    Muzaffer Keklik
    Mustafa Çetin
    Ali Ünal
    Fatih Demirkan
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 282 - 289
  • [28] Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia
    Visco, Carlo
    Moretta, Francesca
    Falisi, Erika
    Facco, Monica
    Maura, Francesco
    Novella, Elisabetta
    Nichele, Ilaria
    Finotto, Silvia
    Giaretta, Ilaria
    Ave, Elisa
    Perbellini, Omar
    Guercini, Nicola
    Scupoli, Maria Teresa
    Trentin, Livio
    Trimarco, Valentina
    Neri, Antonino
    Semenzato, Gianpietro
    Rodeghiero, Francesco
    Pizzolo, Giovanni
    Ambrosetti, Achille
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (04) : 277 - 282
  • [29] Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
    Thomas Elter
    Janne J. Vehreschild
    John Gribben
    Oliver A. Cornely
    Andreas Engert
    Michael Hallek
    Annals of Hematology, 2009, 88 : 121 - 132
  • [30] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) : 2425 - 2437
12345